Justin Burgess is responsible for assisting clients with a variety of valuation engagements primarily related to pre-deal mergers and acquisitions activity, financial reporting, and tax strategy, involving the valuation of businesses, debt and equity securities, partnerships, and intangible assets. His clients include public corporations, private companies, hedge funds, private equity firms, and partnerships.

Mr. Burgess has more than 13 years of experience providing valuation services with a focus on valuation of intangible assets, including trademarks and trade names, certificates of need, patents and developed technology, IPR&D, customer relationships, customer contracts, non-compete agreements, licenses (including healthcare licenses and FCC licenses), and leasehold positions. Mr. Burgess’ experience spans a wide range of industries, with considerable exposure to clients in the healthcare, biotech, technology, manufacturing, and industrial products industries.

Mr. Burgess has extensive experience providing fair value analyses for clients to assist with purchase price allocations, impairment testing, stock compensation, and investment portfolio reporting, including a purchase price allocation for the $5.4 billion acquisition of an animal health business and a goodwill impairment analysis for a $3.0 billion steel and metal products company. He has assisted clients with tax matters involving equity-based compensation, corporate restructuring, asset transfers, gift and estate tax, and tax planning, including an equity-based compensation analysis for both tax and financial reporting purposes for a $1.1 billion construction supply company and the fair market value analysis for transfer planning purposes of a privately-owned company operating nursing and dialysis centers. In his time with PricewaterhouseCoopers LLP, Mr. Burgess served as a valuation specialist to audit teams, including providing review services related to a $24.9 billion transaction to go private by a leading technology firm, a $4.3 billion acquisition of a software firm, and numerous acquisitions by one of the nation’s largest integrated healthcare providers.

Prior to joining BVA, Mr. Burgess was a Manager with PricewaterhouseCoopers LLP in their deals practice in Dallas. Preceding that, Mr. Burgess was a Senior Associate at Kroll Associates, Inc. in their New York and Dallas offices where he specialized in valuation of businesses and intangible assets for a diverse client base.

Mr. Burgess received a Bachelor of Science in Finance from West Virginia University.